Hemorrhoids Market By Product Type (Drugs {OTC and Prescription Drugs}, Devices {Hemorrhoid Banding Devices, Laser Treatment Devices, and Cryotherapy Devices}, and Supplements), By Disease Type (Internal Hemorrhoids, External Hemorrhoids, Prolapsed Hemorrhoids, and Thrombosed Hemorrhoids), By Treatment Type (Surgical Treatments {Hemorrhoidectomy and Stapled Hemorrhoidopexy} and Non-surgical Treatments {Medications and Minimally Invasive Procedures}), By Route of Administration (Topical, Oral, and Injectable), and By End-user (Hospitals, Clinics, Ambulatory Surgical Centers, and Home Care Settings), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Hemorrhoids market accounted for USD 1.46 Billion in 2024 and is expected to reach USD 3.73 Billion by 2035, growing at a CAGR of around 8.9% between 2025 and 2035. The hemorrhoids market is defined as the diagnostic and therapeutic treatment of hemorrhoids, which is the condition of swollen blood vessels in the rectal or anal location. This market comprises topical drugs, such as creams, ointments, and suppositories, and medical procedures like rubber band ligation, sclerotherapy, and surgical procedures in the severe form. The underlying reasons for such treatments are increasing incidences as a result of increased lethargy, unhealthy eating habits, and increasing demographics. The market uses developments in minimally invasive procedures and required treatment for patients.

Report Scope:

Market Dynamics

The rising incidence of hemorrhoids is significantly driven by unhealthy lifestyle choices.

The Hemorrhoids Market is gradually increasing due to poor diets and sedentary lifestyles. Constipation results from low fiber intake and high consumption of processed foods, placing a lot of pressure during defecation are symptoms of hemorrhoids. This situation is particularly irksome for those who work desk-bound jobs where they spend most of the day sitting down, which increases pressure on the rectal veins and leads to it. Moreover, being overweight, a burgeoning problem all across the globe is another cause of hemorrhoids as it contributes to pressure on the abdomen. The elderly population is also vulnerable since they suffer from digestive disorders, and many are less physically active than younger people.

The expensive nature of cutting-edge treatment options may hinder broader patient adoption.

One of the major constraints in the hemorrhoids market is the expensive nature of state-of-the-art treatment, which keeps many patients from being treated. Some treatments are complex, including laser therapy, rubber band ligation, and surgeries like stapled hemorrhoidopexy. These treatments are costly and often with poor insurance support, thus affecting the patients’ pocket. Consequently, many patients prefer purchasing substandard OTC formulations or using folk remedies, which may be ineffective but cheaper. People seeking a diagnosis and treatment are slowed down by the extremely embarrassing feeling that comes with having hemorrhoids.

Furthermore, the availability of such treatment is scarce across many areas, especially in developing countries and rural settings. Such factors, coupled with the ignorance of patients regarding the long-term effectiveness of modern treatments, are impeding the growth of the hemorrhoids market.

The rise of telehealth services allows for easier access to consultations regarding hemorrhoid issues.

The adoption of telehealth services provides a vast potential for the Hemorrhoids Market because many patients consider it shameful to discuss it with a doctor in person. The advantage of having teleconsultations is that people have to get a doctor earlier, resulting in early diagnoses. This creates a context for establishing essential telemedicine solutions for hemorrhoid treatments, including telemonitoring, remote symptom checking, and patient-specific care. Furthermore, telehealth is a feature that helps to increase the demand for professional care in underdeveloped areas for the consumption of OTC and prescription drugs. The patient interaction via digital media improves his/her compliance with prescribed treatments.

Industry Experts Opinion

 "The HemWell - GEN 2 device is designed to revolutionize the traditional hemorrhoidectomy procedure, through a groundbreaking procedure, the Hemwellectomy. HemWell offers patients a significantly less painful experience and a faster return to their daily lives."

• Dr. Stephen Goldman, MD, Chief Medical Officer of Medfiniti B.V. and HemWell MD LLC

Segment Analysis

Based on the product type, the Hemorrhoids Market is classified into Drugs, Devices, and Supplements. Drugs are dominant in the product type segment of Hemorrhoids Market. This dominance is due to the accessibility and effectiveness of sites for over-the-counter and prescription oral OTC drugs, creams, ointments, suppositories, etc. These drugs reduce symptoms like pain, itching, and inflammation and give an immediate result. The increasing consciousness of patients and doctors regarding non-surgical procedures boosts the requirement for pharmaceutical treatments. Although devices and supplements are available, drugs are preferred to them because they are more portable, easily accessible, and cheaper.

Based on the disease type, the Hemorrhoids Market is classified into Internal Hemorrhoids, External Hemorrhoids, Prolapsed Hemorrhoids, and Thrombosed Hemorrhoids. Internal Hemorrhoids are dominant in hemorrhoids market. These develop within the rectum and may go unnoticed in the early stages since they do not present symptoms until they produce pain or blood. Because of sedentary lifestyles, persistent constipation, aging, and other factors, its incidence is higher. Internal hemorrhoids take longer to heal and are likely to end up in a more advanced stage for treatment, like prolapsed hemorrhoids. This segment is especially important because the need for treatment and management solutions for internal hemorrhoids creates a high demand within the market.

Regional Analysis

The North America hemorrhoids market is vibrant due to high incidences of the condition caused by inadequate physical activity, high BMI, and consumption patterns. The region has a large market share because of the developed healthcare system, rising awareness, availability of treatments like OTC medicines, and procedures like liposuction, appendicectomy, etc. Other factors include an increase in the elderly population and a rising demand for non-surgical procedures.

Stakeholders in the area target technological advancements and the availability of patient care services to explain market characteristics. Furthermore, the rising number of research studies and performed clinical trials to increase the effectiveness of therapeutic activities is indicative of the potential market.

The European hemorrhoids market is driven by the prevalence of the aging population and the growing incidence of obesity due to poor eating habits causing digestive problems. Germany, the UK, and France have large market shares because they have well-developed healthcare facilities, and the people in these countries are aware of hemorrhoid treatment. Other factors include the continued adoption of modern technology owing to newer treatment methods like minimally invasive surgeries and enormously extensive OTC [over-the-counter] drugs.

Initiatives by governmental and non-governmental organizations that support early detection and raise awareness led to an increase in demand. Furthermore, an increase in outpatient surgery and increased interest in non-surgical approaches for the treatment of hemorrhoids augment the market growth.

Competitive Landscape

The hemorrhoids market is moderately competitive with key stakeholders such as Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Ethicon, Inc., and Stryker Corporation. Such industries are working hard to establish better treatment options since hemorrhoids are rapidly becoming common. Medtronic's latest advancements in minimally invasive surgical technologies. The company has evolved into exclusive hemorrhoid management devices that have improved procedural output. Further, Johnson & Johnson has progressed to new lines of surgical instruments for use during hemorrhoidectomy procedures. These advancements show that there are great efforts to help patients have better treatment in the hemorrhoids market.

Hemorrhoids Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In December 2023, MEDFINITI B.V. and its U.S. subsidiaries, MEDFINITI, Inc. and HemWell MD LLC, are pleased to announce the arrival in the United States of their ground-breaking product, the "HemWell-GGEN 2," after its FDA 510(k) clearance and technological enhancement.
• In February 2023, MEDFINITI B.V., in collaboration with MEDFINITI, Inc., and HemWell MD LLC, its U.S. subsidiaries, is thrilled to announce the launch of HemWell. This innovative electrosurgical device is revolutionizing the treatment of hemorrhoids.

Report Coverage:

By Product Type

• Drugs
  • OTC
  • Prescription Drugs
• Devices
  • Hemorrhoid Banding Devices
  • Laser Treatment Devices
  • Cryotherapy Devices
• Supplements

By Disease Type

• Internal Hemorrhoids
• External Hemorrhoids
• Prolapsed Hemorrhoids
• Thrombosed Hemorrhoids

By Treatment Type

• Surgical Treatments
  • Hemorrhoidectomy
  • Stapled Hemorrhoidopexy
• Non-surgical Treatments
  • Medications
  • Minimally Invasive Procedures

By Route of Administration

• Topical
• Oral
• Injectable

By End-user

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Home Care Settings

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic plc
• Boston Scientific Corporation
• Johnson & Johnson
• Stryker Corporation
• Cook Medical
• Alcon
• B. Braun Melsungen AG
• Coloplast A/S
• Halyard Health
• Cynosure
• Penumbra, Inc.
• Aesculap
• Medline Industries, Inc.
• Conmed Corporation
• Hologic, Inc.

Frequently Asked Questions (FAQs)